Silencing TCF4 Sensitizes Melanoma Cells to Vemurafenib Through Inhibiting GLUT3-Mediated Glycolysis

Silencing TCF4 Sensitizes Melanoma Cells to Vemurafenib Through Inhibiting GLUT3-Mediated Glycolysis

Can Liu,1 Siqi He,1 Jianfei Zhang,2 Shiyan Li,3 Jian Chen,4 Chaofei Han1 1Department of Burn and Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, People’s Republic of China; 2Department of Burn and Plastic Surgery, The Second Affiliated Hospi...

Full description

Bibliographic Details
Main Authors: Liu C, He S, Zhang J, Li S, Chen J, Han C
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:OncoTargets and Therapy
Subjects:
melanoma
chemotherapy resistance
braf inhibitor
glucose transporter
transcription factor 4
warburg effect
Online Access:https://www.dovepress.com/silencing-tcf4-sensitizes-melanoma-cells-to-vemurafenib-through-inhibi-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/silencing-tcf4-sensitizes-melanoma-cells-to-vemurafenib-through-inhibi-peer-reviewed-article-OTT

Similar Items